Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.40 |
| ▸ | HTR3B | O95264 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.40 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10943745 | 0.94 | SIGMAR1 (0.49) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL10943325 | 0.94 | ALDH1A1 (0.59) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL9679437 | 0.87 | ALDH1A1 (0.50) | SIGMAR1ALDH1A1TSHRHSD17B10MAPK1 | |
| SCHEMBL10943751 | 0.86 | ALDH1A1 (0.49) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL27904024 | 0.85 | SIGMAR1 (0.50) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL3007482 | 0.84 | HPGD (0.48) | ALDH1A1TSHRUSP2HSD17B10MAPK1 | |
| SCHEMBL11896665 | 0.82 | ALDH1A1 (0.46) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL9680403 | 0.82 | HPGD (0.52) | ALDH1A1TSHRUSP2HSD17B10MAPK1 | |
| SCHEMBL2703637 | 0.82 | ALDH1A1 (0.56) | SIGMAR1ALDH1A1TSHRUSP2HSD17B10 | |
| SCHEMBL9681216 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TSHRHSD17B10MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163017-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | NIMMUNE BIOPHARMA, INC. (US) | 2025-05-22 | — | — | US | disclosed |
| US-12145920-B2 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | NIMMUNE BIOPHARMA, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| EP-3927427-B1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | NIMMUNE BIOPHARMA INC (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-113748109-B | Lanthionine C-like protein 2 ligands, cells prepared with said ligands and therapies using said ligands | 朗多生物制药股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-20220274950-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LANDOS BIOPHARMA, INC. (US) | 2022-09-01 | — | — | US | disclosed |
| US-11377437-B2 | Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same | LANDOS BIOPHARMA, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| EP-3927427-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LANDOS BIOPHARMA, INC. (US) | 2021-12-29 | — | — | EP | disclosed |
| CN-113748109-A | Lanthionine C-like protein 2 ligands, cells prepared with said ligands and therapies using said ligands | 朗多生物制药股份有限公司 | 2021-12-03 | — | — | CN | disclosed |
| US-20210355101-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LANDOS BIOPHARMA, INC. (US) | 2021-11-18 | — | — | US | disclosed |
| US-11117881-B2 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | LANDOS BIOPHARMA, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| US-20070160921-A1 | Electrophotographic photoconductor, method of producing the same and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2007-07-12 | — | — | US | disclosed |
| US-20070160921-A1 | Electrophotographic photoconductor, method of producing the same and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2007-07-12 | — | — | US | disclosed |
| US-5145885-A | Morpholine compound, binders | CIBA-GEIGY CORPORATION (US) | 1992-09-08 | — | — | US | disclosed |
| US-4992547-A | Aminoaryl ketone photoinitiators | CIBA-GEIGY CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| US-4960746-A | A-HYDROXY-OR A-AMINO-ACETOPHENONES AND A TITANOCENE COMPOUND SUBSTITUTED BY FLUORINE | CIBA-GEIGY CORPORATION (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0003002-B1 | USE OF AROMATIC-ALIPHATIC KETONES AS PHOTOINITIATORS, PHOTOPOLYMERISABLE SYSTEMS CONTAINING SUCH KETONES AND AROMATIC-ALIPHATIC KETONES | CIBA-GEIGY AG (CH) | 1984-06-13 | — | — | EP | disclosed |
| US-4321118-A | Bis benzoyl sensitizers for photopolymerization or photo cross linking process and composition | CIBA-GEIGY CORPORATION (US) | 1982-03-23 | — | — | US | disclosed |
| US-4318791-A | PHOTOPOLYMERIZABLE SYSTEM FOR INKS | CIBA-GEIGY CORPORATION (US) | 1982-03-09 | — | — | US | disclosed |
| US-4315807-A | Sensitizers for photopolymerization | CIBA-GEIGY CORPORATION (US) | 1982-02-16 | — | — | US | disclosed |
| US-4308400-A | AROMATIC HYDROXY KETONES | CIBA-GEIGY A.G. (CH) | 1981-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163017-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
| US-11377437-B2 | Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
| US-20210355101-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
| US-12145920-B2 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
| US-11117881-B2 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
| US-20220274950-A1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | LCP2, LANCL2, SSB | SIGMAR1 3734/4885ALDH1A1 4546/4885TSHR 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.